STAAR Surgical (NASDAQ:STAA) Given Average Recommendation of "Hold" by Analysts

STAAR Surgical (NASDAQ:STAA - Get Free Report) has earned a consensus recommendation of "Hold" from the nine brokerages that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and four have issued a buy rating on the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $42.83.

Several analysts recently issued reports on STAA shares. Canaccord Genuity Group cut their price target on shares of STAAR Surgical from $31.00 to $28.00 and set a "hold" rating on the stock in a report on Monday. Stifel Nicolaus cut their target price on shares of STAAR Surgical from $50.00 to $44.00 and set a "buy" rating on the stock in a research note on Monday, August 26th. Needham & Company LLC reiterated a "hold" rating on shares of STAAR Surgical in a research note on Thursday, October 31st. Finally, Stephens upgraded STAAR Surgical to a "hold" rating in a research note on Monday, December 2nd.

Hedge Funds Weigh In On STAAR Surgical

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Arcadia Investment Management Corp MI bought a new stake in shares of STAAR Surgical in the 3rd quarter worth approximately $37,000. Quarry LP bought a new stake in STAAR Surgical in the third quarter valued at $50,000. Quest Partners LLC acquired a new position in shares of STAAR Surgical during the third quarter valued at $128,000. Canada Pension Plan Investment Board bought a new position in shares of STAAR Surgical during the second quarter worth about $129,000. Finally, Van ECK Associates Corp increased its holdings in shares of STAAR Surgical by 12.7% in the 3rd quarter. Van ECK Associates Corp now owns 3,478 shares of the medical instruments supplier's stock worth $129,000 after acquiring an additional 393 shares during the period. 96.70% of the stock is currently owned by institutional investors and hedge funds.

STAAR Surgical Stock Up 0.6 %

Shares of STAA traded up $0.14 during trading on Thursday, reaching $25.39. The company's stock had a trading volume of 507,360 shares, compared to its average volume of 702,207. The company has a market cap of $1.25 billion, a price-to-earnings ratio of 57.70 and a beta of 0.59. The company has a fifty day moving average of $29.11 and a two-hundred day moving average of $35.12. STAAR Surgical has a twelve month low of $25.04 and a twelve month high of $52.68.

About STAAR Surgical

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.